Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Chris Lange | Apr 17, 2018 at 9:45 AM EDT

Johnson & Johnson Earnings Just Par for the Course

Johnson & Johnson (NYSE: JNJ) reported its first quarter financial results before the markets opened on Tuesday. The company said…

Chris Lange | Apr 15, 2018 at 10:20 AM EDT

GE, Goldman Sachs, IBM and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of GE, IBM and the other Dow Jones Industrial Average companies scheduled…

Jon C. Ogg | Apr 13, 2018 at 12:10 PM EDT

7 Companies That Have Raised Their Dividends for at Least 50 Straight Years

Here are seven companies that have 50 straight years or more of raising their dividends, as well as several runners-up.

Jon C. Ogg | Apr 12, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp, Southwest Air and More

The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson,…

Paul Ausick | Apr 3, 2018 at 4:01 PM EDT

Nike, UnitedHealth Lift Dow on Tuesday

Nike, UnitedHealth, DowDuPont, and Johnson & Johnson were among the Dow's best performing stock's Tuesday.

Paul Ausick | Mar 24, 2018 at 10:20 AM EDT

8 Biggest Dow Losers So Far in 2018

The eight worst performing Dow stocks for 2018 have all lost at least 10% of their value for the year…

Paul Ausick | Mar 8, 2018 at 4:07 PM EST

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

The Dow wobbled around Thursday and looks set to close very near the break-even line as J&J, Pfizer, Caterpillar, and…

Jon C. Ogg | Mar 2, 2018 at 10:20 AM EST

10 Defensive Stocks Holding Strong as the Market Sell-Off Gains Momentum

Here are 10 defensive stocks, including Verizon Communications and Coca-Cola, trading higher during this latest market sell-off.

Paul Ausick | Feb 16, 2018 at 4:01 PM EST

Pfizer, UnitedHealth Boost DJIA on Friday

Pfizer, UnitedHealth, Disney, and Johnson & Johnson lifted the DJIA on Friday.

Jon C. Ogg | Feb 14, 2018 at 4:55 PM EST

Warren Buffett and Berkshire Hathaway Reveal Top Stocks for 2018

24/7 Wall St. has tracked many of the so-called whale watching trades made by America's top investment managers, hedge fund…

Chris Lange | Feb 9, 2018 at 4:08 PM EST

5 Defensive Stocks Holding Up in Friday’s Extreme Volatility

Over the course of the last few trading days, we have seen the return of volatility and some serious carnage…

Chris Lange | Feb 7, 2018 at 11:10 AM EST

Why Theravance Biopharma Shares Are Soaring

Theravance Biopharma shares made a solid gain on Wednesday after the company announced a global collaboration with Janssen Biotech.

Jon C. Ogg | Feb 6, 2018 at 8:45 AM EST

How Top and Most Widely Held Stocks Are Holding Up in the Panic Selling

24/7 Wall St. is addressing some of the top market darlings and most widely held stocks by the public. We…

Jon C. Ogg | Feb 6, 2018 at 7:00 AM EST

15 Defensive Stocks That Will Survive the Stock Market Meltdown

24/7 Wall St. has chosen a list of companies that will operate fine in times of market turmoil and probably…

Paul Ausick | Feb 5, 2018 at 4:01 PM EST

Chevron, Exxon Drag DJIA Down Monday

Chevron, Exxon, 3M, and Johnson & Johnson led all 30 DJIA stocks on a second-consecutive unanimous tumble.

1 … 25 26 27 28 29 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Earnings Just Par for the Course

GE, Goldman Sachs, IBM and More Dow Earnings Coming This Week

7 Companies That Have Raised Their Dividends for at Least 50 Straight Years

Top Analyst Upgrades and Downgrades: Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp, Southwest Air and More

Nike, UnitedHealth Lift Dow on Tuesday

8 Biggest Dow Losers So Far in 2018

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

10 Defensive Stocks Holding Strong as the Market Sell-Off Gains Momentum

Pfizer, UnitedHealth Boost DJIA on Friday

Warren Buffett and Berkshire Hathaway Reveal Top Stocks for 2018

5 Defensive Stocks Holding Up in Friday’s Extreme Volatility

Why Theravance Biopharma Shares Are Soaring

How Top and Most Widely Held Stocks Are Holding Up in the Panic Selling

15 Defensive Stocks That Will Survive the Stock Market Meltdown

Chevron, Exxon Drag DJIA Down Monday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Earnings Just Par for the Course

GE, Goldman Sachs, IBM and More Dow Earnings Coming This Week

7 Companies That Have Raised Their Dividends for at Least 50 Straight Years

Top Analyst Upgrades and Downgrades: Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp, Southwest Air and More

Nike, UnitedHealth Lift Dow on Tuesday

8 Biggest Dow Losers So Far in 2018

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

10 Defensive Stocks Holding Strong as the Market Sell-Off Gains Momentum

Pfizer, UnitedHealth Boost DJIA on Friday

Warren Buffett and Berkshire Hathaway Reveal Top Stocks for 2018

5 Defensive Stocks Holding Up in Friday’s Extreme Volatility

Why Theravance Biopharma Shares Are Soaring

How Top and Most Widely Held Stocks Are Holding Up in the Panic Selling

15 Defensive Stocks That Will Survive the Stock Market Meltdown

Chevron, Exxon Drag DJIA Down Monday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts